Abstract

Whipworms are large metazoan parasites that inhabit multi-intracellular epithelial tunnels in the large intestine of their hosts, causing chronic disease in humans and other mammals. How first-stage larvae invade host epithelia and establish infection remains unclear. Here we investigate early infection events using both Trichuris muris infections of mice and murine caecaloids, the first in-vitro system for whipworm infection and organoid model for live helminths. We show that larvae degrade mucus layers to access epithelial cells. In early syncytial tunnels, larvae are completely intracellular, woven through multiple live dividing cells. Using single-cell RNA sequencing of infected mouse caecum, we reveal that progression of infection results in cell damage and an expansion of enterocytes expressing of Isg15, potentially instigating the host immune response to the whipworm and tissue repair. Our results unravel intestinal epithelium invasion by whipworms and reveal specific host-parasite interactions that allow the whipworm to establish its multi-intracellular niche.

Whipworms are large parasites causing chronic disease in humans and other mammals. Here, the authors show how larvae create tunnels inside the gut lining and reveal the early host response to infection via Isg15 in mice and murine caecaloids.

Details

Title
Defining the early stages of intestinal colonisation by whipworms
Author
Duque-Correa, María A 1   VIAFID ORCID Logo  ; Goulding, David 2 ; Rodgers, Faye H 3 ; Andrew, Gillis J 4 ; Cormie Claire 1 ; Rawlinson, Kate A 2   VIAFID ORCID Logo  ; Bancroft, Allison J 5 ; Bennett, Hayley M 6   VIAFID ORCID Logo  ; Lotkowska, Magda E 2 ; Reid, Adam J 7   VIAFID ORCID Logo  ; Speak, Anneliese O 2   VIAFID ORCID Logo  ; Scott, Paul 2 ; Redshaw, Nicholas 2 ; Tolley, Charlotte 2   VIAFID ORCID Logo  ; McCarthy, Catherine 2 ; Brandt, Cordelia 2 ; Sharpe, Catherine 8 ; Ridley, Caroline 9 ; Moya, Judit Gali 10 ; Carneiro, Claudia M 11   VIAFID ORCID Logo  ; Starborg Tobias 12 ; Hayes, Kelly S 5   VIAFID ORCID Logo  ; Holroyd, Nancy 2 ; Sanders, Mandy 2 ; Thornton, David J 5   VIAFID ORCID Logo  ; Grencis, Richard K 5   VIAFID ORCID Logo  ; Berriman, Matthew 2   VIAFID ORCID Logo 

 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); University of Cambridge, Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672) 
 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); Mogrify Ltd, 25 Cambridge Science Park, Cambridge, UK (GRID:grid.52788.30) 
 University of Cambridge, Department of Zoology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); Genentech, 1 DNA Way, South San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718) 
 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672); University of Cambridge, Wellcome/Cancer Research UK Gurdon Institute, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); InstilBio, UMIC Bio-Incubator, Manchester, UK (GRID:grid.5379.8) 
 Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Prime Global Medical Communications, Knutsford, UK (GRID:grid.5379.8) 
10  University of Barcelona, Faculty of Biology, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247) 
11  Federal University of Ouro Preto, Campus Universitario Morro do Cruzeiro, Immunopathology Laboratory, NUPEB, Ouro Preto, Brazil (GRID:grid.411213.4) (ISNI:0000 0004 0488 4317) 
12  Medicine and Health, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Wellcome Trust Centre for Cell Matrix Research and Faculty of Biology, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407); Rosalind Franklin Institute, Didcot, UK (GRID:grid.507854.b) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2646023307
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.